Pierce A - Search Results

1

Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer.

Njoku K, Campbell AE, Geary B, MacKintosh ML, Derbyshire AE, Kitson SJ, Sivalingam VN, Pierce A, Whetton AD, Crosbie EJ. Njoku K, et al. Among authors: pierce a. Cancers (Basel). 2021 Feb 10;13(4):718. doi: 10.3390/cancers13040718. Cancers (Basel). 2021. PMID: 33578729 Free PMC article.

2

Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.

Chasty RC, Lucas GS, Owen-Lynch PJ, Pierce A, Whetton AD. Chasty RC, et al. Among authors: pierce a. Blood. 1995 Dec 1;86(11):4270-7. Blood. 1995. PMID: 7492787 Free article.

3

Haemopoietic growth factors and leukaemogenesis.

Pierce A, Whetton AD. Pierce A, et al. Biochem Soc Trans. 1997 May;25(2):366-70. doi: 10.1042/bst0250366. Biochem Soc Trans. 1997. PMID: 9191119 Review. No abstract available.

4

p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.

Pierce A, Owen-Lynch PJ, Spooncer E, Dexter TM, Whetton AD. Pierce A, et al. Oncogene. 1998 Aug 6;17(5):667-72. doi: 10.1038/sj.onc.1201969. Oncogene. 1998. PMID: 9704934

5

Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells.

Francis JM, Heyworth CM, Spooncer E, Pierce A, Dexter TM, Whetton AD. Francis JM, et al. Among authors: pierce a. J Biol Chem. 2000 Dec 15;275(50):39137-45. doi: 10.1074/jbc.M007212200. J Biol Chem. 2000. PMID: 10993901 Free article.

6

The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells.

Buckle AM, Mottram R, Pierce A, Lucas GS, Russell N, Miyan JA, Whetton AD. Buckle AM, et al. Among authors: pierce a. Mol Med. 2000 Oct;6(10):892-902. Mol Med. 2000. PMID: 11126203 Free PMC article.

7

The specific enhancement of interferon alpha induced growth inhibition by BCR/ABL only occurs in multipotent cells.

Pierce A, Smith DL, Jakobsen LV, Whetton AD, Spooncer E. Pierce A, et al. Hematol J. 2001;2(4):257-64. doi: 10.1038/sj.thj.6200114. Hematol J. 2001. PMID: 11920258

8

BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor.

Pierce A, Spooncer E, Ainsworth S, Whetton AD. Pierce A, et al. Oncogene. 2002 May 2;21(19):3068-75. doi: 10.1038/sj.onc.1205424. Oncogene. 2002. PMID: 12082538

9

Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors.

Evans CA, Ariffin S, Pierce A, Whetton AD. Evans CA, et al. Among authors: pierce a. Blood. 2002 Nov 1;100(9):3164-74. doi: 10.1182/blood-2001-12-0235. Blood. 2002. PMID: 12384414 Free article.

10

Changes in the proteome associated with the action of Bcr-Abl tyrosine kinase are not related to transcriptional regulation.

Smith DL, Evans CA, Pierce A, Gaskell SJ, Whetton AD. Smith DL, et al. Among authors: pierce a. Mol Cell Proteomics. 2002 Nov;1(11):876-84. doi: 10.1074/mcp.m200035-mcp200. Mol Cell Proteomics. 2002. PMID: 12488463 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

924 results

Search Page

Filters